Cite
HARVARD Citation
Di Bartolomeo, M. et al. (n.d.). Capecitabine, oxaliplatin and irinotecan in combination, with bevacizumab (COI-B regimen) as first-line treatment of patients with advanced colorectal cancer. An Italian Trials of Medical Oncology phase II study. European journal of cancer. 51 (4), pp. 473-481. [Online].